127 related articles for article (PubMed ID: 26497523)
21. CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.
Selb R; Eckl-Dorna J; Neunkirchner A; Schmetterer K; Marth K; Gamper J; Jahn-Schmid B; Pickl WF; Valenta R; Niederberger V
J Allergy Clin Immunol; 2017 Jan; 139(1):290-299.e4. PubMed ID: 27372566
[TBL] [Abstract][Full Text] [Related]
22. Tracing IgE-Producing Cells in Allergic Patients.
Eckl-Dorna J; Villazala-Merino S; Campion NJ; Byazrova M; Filatov A; Kudlay D; Karsonova A; Riabova K; Khaitov M; Karaulov A; Niederberger-Leppin V; Valenta R
Cells; 2019 Aug; 8(9):. PubMed ID: 31466324
[TBL] [Abstract][Full Text] [Related]
23. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
Jabs F; Plum M; Laursen NS; Jensen RK; Mølgaard B; Miehe M; Mandolesi M; Rauber MM; Pfützner W; Jakob T; Möbs C; Andersen GR; Spillner E
Nat Commun; 2018 Jan; 9(1):7. PubMed ID: 29295972
[TBL] [Abstract][Full Text] [Related]
24. Targeting IgE in allergic disease.
Gasser P; Eggel A
Curr Opin Immunol; 2018 Oct; 54():86-92. PubMed ID: 29986302
[TBL] [Abstract][Full Text] [Related]
25. IgE binds asymmetrically to its B cell receptor CD23.
Dhaliwal B; Pang MO; Keeble AH; James LK; Gould HJ; McDonnell JM; Sutton BJ; Beavil AJ
Sci Rep; 2017 Mar; 7():45533. PubMed ID: 28361904
[TBL] [Abstract][Full Text] [Related]
26. IgE Glycosylation in Health and Disease.
Shade KT; Conroy ME; Anthony RM
Curr Top Microbiol Immunol; 2019; 423():77-93. PubMed ID: 30820668
[TBL] [Abstract][Full Text] [Related]
27. Identification of IgE.
Ishizaka K; Ishizaka T
J Allergy Clin Immunol; 2016 Jun; 137(6):1646-1650. PubMed ID: 27090936
[TBL] [Abstract][Full Text] [Related]
28. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab.
Davies AM; Allan EG; Keeble AH; Delgado J; Cossins BP; Mitropoulou AN; Pang MOY; Ceska T; Beavil AJ; Craggs G; Westwood M; Henry AJ; McDonnell JM; Sutton BJ
J Biol Chem; 2017 Jun; 292(24):9975-9987. PubMed ID: 28438838
[TBL] [Abstract][Full Text] [Related]
29. Roles of omalizumab in various allergic diseases.
Okayama Y; Matsumoto H; Odajima H; Takahagi S; Hide M; Okubo K
Allergol Int; 2020 Apr; 69(2):167-177. PubMed ID: 32067933
[TBL] [Abstract][Full Text] [Related]
30. Past, present, and future of anti-IgE biologics.
Guntern P; Eggel A
Allergy; 2020 Oct; 75(10):2491-2502. PubMed ID: 32249957
[TBL] [Abstract][Full Text] [Related]
31. A new look at IgE beyond allergies.
Luker AJ; Lownik JC; Conrad DH; Martin RK
F1000Res; 2019; 8():. PubMed ID: 31168357
[TBL] [Abstract][Full Text] [Related]
32. IgY: a key isotype in antibody evolution.
Zhang X; Calvert RA; Sutton BJ; Doré KA
Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2144-2156. PubMed ID: 28299878
[TBL] [Abstract][Full Text] [Related]
33. The discovery of IgE.
Johansson SGO
J Allergy Clin Immunol; 2016 Jun; 137(6):1671-1673. PubMed ID: 27264002
[TBL] [Abstract][Full Text] [Related]
34. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab.
Gasser P; Tarchevskaya SS; Guntern P; Brigger D; Ruppli R; Zbären N; Kleinboelting S; Heusser C; Jardetzky TS; Eggel A
Nat Commun; 2020 Jan; 11(1):165. PubMed ID: 31913280
[TBL] [Abstract][Full Text] [Related]
35. The role of CD23 in the regulation of allergic responses.
Engeroff P; Vogel M
Allergy; 2021 Jul; 76(7):1981-1989. PubMed ID: 33378583
[TBL] [Abstract][Full Text] [Related]
36. CD23 is a glycan-binding receptor in some mammalian species.
Jégouzo SAF; Feinberg H; Morrison AG; Holder A; May A; Huang Z; Jiang L; Lasanajak Y; Smith DF; Werling D; Drickamer K; Weis WI; Taylor ME
J Biol Chem; 2019 Oct; 294(41):14845-14859. PubMed ID: 31488546
[TBL] [Abstract][Full Text] [Related]
37. Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation.
Villazala-Merino S; Rodriguez-Dominguez A; Stanek V; Campion NJ; Gattinger P; Hofer G; Froeschl R; Fae I; Lupinek C; Vrtala S; Breiteneder H; Keller W; Perkmann T; Nakamura R; Pickl WF; Valenta R; Eckl-Dorna J; Niederberger V
J Allergy Clin Immunol; 2020 Mar; 145(3):958-967.e5. PubMed ID: 31775017
[TBL] [Abstract][Full Text] [Related]
38. Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.
Pennington LF; Tarchevskaya S; Brigger D; Sathiyamoorthy K; Graham MT; Nadeau KC; Eggel A; Jardetzky TS
Nat Commun; 2016 May; 7():11610. PubMed ID: 27194387
[TBL] [Abstract][Full Text] [Related]
39. CD23 can negatively regulate B-cell receptor signaling.
Liu C; Richard K; Wiggins M; Zhu X; Conrad DH; Song W
Sci Rep; 2016 May; 6():25629. PubMed ID: 27181049
[TBL] [Abstract][Full Text] [Related]
40. The discovery of immunoglobulin E.
Ribatti D
Immunol Lett; 2016 Mar; 171():1-4. PubMed ID: 26772434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
